Sono-Tek H1 Medical Revenue Soars 289% to $7.1M, Backlog Up 23%
SOTK sits 86% above its 52-week low of $3.4 on elevated volume (4.9× avg).
Summary
Sono-Tek's H1 medical revenue jumped 289% to about $7.1M, driven by drug-eluting balloon coating and specialty stent coatings. Backlog rose 23% quarter-over-quarter to $9.5M as of August 31, including three orders from an existing alternative-energy customer totaling roughly $7.2M, mainly shipping in fiscal 2028. This follows yesterday's Q2 FY27 report showing medical sales up 209% and gross margin expanding to 53%. The medical segment is now the clear growth engine, offsetting an 85% decline in Advanced Energy. The $7.2M clean-energy order pipeline provides multi-year revenue visibility.
At the time of this announcement, SOTK was trading at $6.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $97.5M. The 52-week trading range was $3.40 to $7.48. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.